Constructing a novel chimeric multiepitope vaccine against Simian immunodeficiency virus accessory proteins: Using...

Area of Science:

• Immunology
• Bioinformatics
• Virology

Background:

• Simian immunodeficiency virus (SIV) is an evolutionary precursor to HIV, sharing similar disease progression and transmission in rhesus macaques.
• SIV serves as a crucial model for developing HIV/SIV preventative strategies.

Purpose of the Study:

• To computationally design a multiepitope vaccine construct targeting Simian immunodeficiency virus (SIV).
• To evaluate the potential immunogenicity and efficacy of SIV accessory proteins (Nef, Vif, Vpr, Vpx) for vaccine development.

Main Methods:

• Utilized computational immunology and bioinformatics tools for epitope prediction and screening.
• Assembled selected SIV epitopes into a multiepitope construct with an adjuvant.
• Performed structural modeling, molecular docking against Toll-like receptors (TLRs), and molecular dynamics simulations.
• Employed immune simulation models to predict vaccine performance.

Main Results:

• Identified 30 immunogenic SIV epitopes meeting antigenicity, non-toxicity, and non-allergenicity criteria.
• The designed construct showed favorable binding to TLR2, TLR3, TLR4, TLR7, and TLR9.
• Computational analyses confirmed structural stability and predicted strong antibody and cellular immune responses.

Conclusions:

• The in silico designed SIV multiepitope vaccine construct shows potential for eliciting broad and durable immune responses.
• This study highlights the utility of computational approaches in accelerating early-stage vaccine design for SIV.